Colistin neurotoxicity: Revisited

BMJ Case Reports

Volumn 2015, Issue , 2015, Pages

  Nigam, Aruna ^a   Kumari, Archana ^a   Jain, Reena ^a   Batra, Swaraj ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; GENTAMICIN; MEROPENEM; METRONIDAZOLE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ABDOMINAL INJURY; ABDOMINAL SURGERY; ADULT; ANEMIA; ARTICLE; BLOOD TRANSFUSION; BRAIN DISEASE; CASE REPORT; CESAREAN SECTION; CHILL; DROWSINESS; DRUG WITHDRAWAL; DYSTOCIA; FEMALE; FEVER; FOLLOW UP; GLASGOW COMA SCALE; HALLUCINATION; HOSPITAL DISCHARGE; HUMAN; MEDICAL EXAMINATION; NEUROTOXICITY; OUTCOME ASSESSMENT; PAIN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RIGOR; SUPPURATION; SURGICAL WOUND; YOUNG ADULT; BRAIN DISEASES; CHEMICALLY INDUCED; DRUG EFFECTS; MICROBIOLOGY; NEUROTOXICITY SYNDROMES; PATHOGENICITY; PSEUDOMONAS; PSEUDOMONAS INFECTIONS; RESPIRATORY INSUFFICIENCY;

ANTI-BACTERIAL AGENTS; BRAIN DISEASES; COLISTIN; FEMALE; HUMANS; NEUROTOXICITY SYNDROMES; PSEUDOMONAS; PSEUDOMONAS INFECTIONS; RESPIRATORY INSUFFICIENCY; YOUNG ADULT;

EID: 84941312538     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2015-210787     Document Type: Article

References (12)

1. Falagas ME, Kasiakou SK. Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis 2005;40:1333-41.
2. Nation RL, Li J. Colistin in the 21st century. Curr Opin Infect Dis 2009;22:535-43.
3. Li J, Nation RL, Milne RW, et al. Evaluation of colistin as an agent against multi-resistant gram-negative bacteria. Int J Antimicrob Agents 2005;25:11-25.
4. Cheng CY, Sheng WH, Wang JT, et al. Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant gram-negative bacterial infections. Int J Antimicrob Agents 2010;25:297-300.
5. Santamaria C, Mykietiuk A, Temporiti E, et al. Nephrotoxicity associated with the use of intravenous colistin. Scand J Infect Dis 2009;41:767-9.
6. Hartzell J, Neff R, Ake J, et al. Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center. Clin Infect Dis 2009;48:1724-8.
7. Molina J, Cordero E, Pachon J. New Information about the polymyxin/colistin class of antibiotics. Expert Opin Pharmacother 2009;10:2811-28.
8. Falagas ME, Kasiakou SK. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care 2006;10:R27.
9. Spapen H, Jacobs R, Van Gorp V, et al. Renal and neurological side effects of colistin in critically ill patients. Ann Intensive Care 2011;1:14.
10. Wolinsky E, Hines JD. Neurotoxic and nephrotoxic effects of colistin in patients with renal disease. N Engl J Med 1972;266:759-62.
11. Koch-Weser J, Sidel VW, Federman EB, et al. Adverse effects of sodium colistimethate: manifestations and specific rates during 317 courses of therapy. Ann Intern Med 1970;72:857-68.
12. Duncan DA. Colistin toxicity. Neuromuscular and renal manifestations. Two cases treated by hemodialysis. Minn Med 1973;56:31-5.